Pharma News Related News
UK scientists discover an effective new spinal cord injury treatment
A group of UK-based researchers at the University of Birmingham have potentially identified a powerful new spinal cord injury treatment, discovering that an existing...
World’s first drug treatment for cataracts could be available soon
The first ever drug treatment for cataracts could be on the market imminently, with a team of international scientists at Anglia Ruskin University (ARU)...
Life-saving arthritis drugs can treat Covid patients
The NHS is repurposing a cutting-edge arthritis drug to treat the most seriously ill Covid patients in the hospital.
The RECOVERY trial carried out through the...
Montelukast drug for asthma blocks vital COVID-19 protein
Researchers from the Indian Institute of Science (IISc) have discovered that a drug commonly used to treat asthma and allergies – montelukast – can...
Scientists identify a range of new bladder cancer treatments
A study performed at MedUni Vienna has discovered hundreds of new potential bladder cancer treatments, with one commonly used drug demonstrating effectiveness against two...
Male contraceptive pill could be on the market soon
Scientists have potentially achieved a significant milestone towards developing a male contraceptive pill, a major advancement for birth control for men.
Pioneered by researchers at...
Molnupiravir recommended by WHO to reduce COVID-19 hospitalisations
The World Health Organization (WHO) has expressed that the molnupiravir antiviral medication should be administered to patients with non-severe COVID-19 who are at an...
Azithromycin does not prevent future wheezing in babies with RSV infection
New research of azithromycin suggests the antibiotic does not prevent wheezing in babies hospitalised with RSV infection.
Respiratory syncytial virus (RSV) infection is a common...
Inhaled vaccine for COVID-19 protects against variants of concern
In a groundbreaking development toward curbing the transmission of SARS-CoV-2, scientists have developed an innovative inhaled vaccine for COVID-19 that offers robust disease protection.
Pioneered...
Cyproterone acetate drug may increase benign brain tumour risk
A UK study has signified that high doses of a commonly used hormonal treatment – cyproterone acetate – may elevate the risk of benign...
Zika vaccine demonstrates effectiveness at preventing the virus
A groundbreaking Zika vaccine has been proven to prevent the Zika virus effectively in preclinical animal studies.
The novel Zika vaccine was developed at the...
Big Boost for NervGen’s Phase II Clinical Trials
In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
Repurposed Alzheimer’s medication provides new glioblastoma treatment
Exciting new research has identified that a drug previously prescribed for Alzheimer's disease may work as an effective glioblastoma treatment.
An investigation conducted by Cleveland...
Pancreatic cancer immunotherapy enhanced by new experimental drug
A team of researchers has identified a novel experimental drug that effectively boosts the efficacy of pancreatic cancer immunotherapy, potentially a landmark breakthrough in...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
Versatile Accum technology for various immune-oncology needs
Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics.
The principal technology developed by Defence Therapeutics (DT)...
Viagra shown to suppress abnormal heart rhythms
The drug sildenafil, sold under the brand name Viagra, can strongly suppress abnormal heart rhythms, a new study has found.
In a study led by...
Pfizer-BionNTech vaccine side effects mild to moderate in high-risk children
The side effects of the Pfizer-BionNTech vaccine in clinically vulnerable 12- to 15-year-olds are likely to be minimal, a study has shown.
In a small...
$1.5m funding will further research towards TB vaccine
The VALIDATE Network has received a $1.5m funding boost to support its development of a tuberculosis (TB) vaccine.
The Bill & Melinda Gates Foundation have...
COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers
The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said.
Following the first large-scale population-based study...
